O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine Synthesis via Catalytic Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing macrolide antibiotics, particularly erythromycin derivatives, face challenges in yield and process complexity, especially in producing compounds like O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine, which is crucial for synthesizing active compounds against MLSB-resistant bacteria.
Innovation Solution
A process involving the reaction of pyridyl derivatives with pyrazole in the presence of acids, bases, or metallic catalysts to enhance yield and simplify the production of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine, including steps such as treating 2-chloro-5-chloromethyl-pyridine with compounds R1R2NOH and reacting pyrazole with intermediates in the presence of acids or bases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current synthesis methods are used for O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine, then the compound can be produced, but the product yield is low and the process complexity is high
Solution Approach 1:
The synthesis process is divided into distinct modular steps: (1) reaction of pyridyl derivatives with pyrazole in the presence of catalysts to form intermediate compounds, (2) subsequent transformation steps with specific reagents, and (3) final product formation. This segmentation allows each step to be optimized independently, improving overall yield while maintaining clear process control.
Solution Approach 2:
The patent employs parameter changes by utilizing different catalysts (acids, bases, or metallic catalysts) and adjusting reaction conditions such as temperature, solvent type, and reagent ratios to optimize each synthesis step. This enables high yield production while simplifying the overall process through controlled parameter variation rather than complex multi-step procedures.
2Productivity
If current synthesis methods are used for O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine, then the compound can be produced, but the number of process steps is high
Solution Approach 1:
The patent merges multiple transformations into a streamlined sequence where pyridyl derivatives react with pyrazole in the presence of catalysts to directly form the desired hydroxylamine compound through coordinated reaction steps. This combining of operations reduces the total number of isolated process steps while maintaining high production efficiency.
Solution Approach 2:
The synthesis employs preliminary action by pre-activating pyridyl derivatives and selecting appropriate catalysts before the main reaction occurs. This preliminary preparation enables the subsequent steps to proceed more efficiently with fewer intermediate interventions, reducing the overall number of process steps required.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases the product yield and reduces process steps, making large-scale production more efficient and effective for compounds useful in synthesizing erythromycin derivatives with enhanced antibacterial activity against resistant strains.
Implementation Method 1
pyridyl derivatives of formulae I are reacted with pyrazole in the presence of acids, bases or metallic catalysts
Data Source
AI summary
The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):